Table S1. Comparison of clinical characteristics and treatment outcomes between the patients who refused surgery and those who underwent surgery.
| Variables | Patients who refused surgery (n=4) | Patients who underwent surgery (n=11) | P value |
|---|---|---|---|
| Age, years | 62 [48–72] | 43 [17–54] | 0.050 |
| Sex, male | 1 (25.0) | 6 (54.5) | 0.569 |
| BMI, kg/m2 | 26.6 (20.1–28.9) | 20.7 (19.4–21.9) | 0.150 |
| Steroid* | 3 (75.0) | 4 (36.4) | 0.282 |
| Steroid dose, mg | 20.0 (NA) | 55.0 (40.0–81.3) | 0.476 |
| Steroid duration, days | 43 (NA) | 24 [18–30] | 0.034 |
| Combined infection | |||
| Blood stream infection | 1 (25.0) | 1 (9.1) | 0.476 |
| CMV infection | 0 | 0 | – |
| Radiological findings | |||
| Longest diameter, mm | 75 [43–125] | 46 [26–55] | 0.191 |
| Pleural effusion | 3 (75.0) | 4 (36.4) | 0.282 |
| SOFA score | 6 [3–10] | 3 [2–4] | 0.054 |
| Use of mechanical ventilation** | 3 (75.0) | 3 (27.3) | 0.235 |
| Use of mechanical ventilation ≥3 days | 0 (0) | 0 (0) | – |
| Treatment outcomes | |||
| Survived | 1 (25.0) | 10 (90.9) | 0.033 |
Values are number (%) or median (interquartile range). *, defined as steroid use of ≥1 month; **, defined as use of mechanical ventilation at the time of decision of surgical resection. BMI, body mass index; NA, not applicable; CMV, cytomegalovirus; SOFA, sequential organ failure assessment.